Virtual tissue technology reveals new drug target in polycystic kidney disease
Using virtual tissue technology, researchers have identified a potential new drug target in the fight against polycystic kidney disease, an illness with no effective FDA-approved treatment that affects 200,000 people per year in the United States. The study reveals that errors in how cells stick together give rise to two forms of kidney cysts.
Leave a Reply